VEGF, HIF-1α Expression and MVD as an Angiogenic Network in Familial Breast Cancer

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Saponaro, Concetta ^a   Malfettone, Andrea ^a   Ranieri, Girolamo ^a   Danza, Katia ^a   Simone, Giovanni ^a   Paradiso, Angelo ^a   Mangia, Anita ^a  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HORMONE RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROGESTERONE RECEPTOR; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; BREAST CANCER; CANCER GRADING; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS REACTION; DISEASE CARRIER; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MICROVASCULATURE; PROTEIN EXPRESSION; TUMOR VOLUME; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FAMILY HEALTH; FEMALE; HETEROZYGOTE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84872346471     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053070     Document Type: Article

References (56)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, et al. (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18 (3):: 581-592 doi: mdl498 [pii]10.1093/annonc/mdl498.
2. Fernandez-Ramires R, Gomez G, Munoz-Repeto I, de Cecco L, Llort G, et al. (2011) Transcriptional characteristics of familial non-BRCA1/BRCA2 breast tumors. Int J Cancer 128 (11):: 2635-2644 doi:10.1002/ijc.25603.
3. Vargas AC, Reis-Filho JS, Lakhani SR, (2011) Phenotype-genotype correlation in familial breast cancer. J Mammary Gland Biol Neoplasia 16 (1):: 27-40 doi:10.1007/s10911-011-9204-6.
4. van der Groep P, van der Wall E, van Diest PJ, (2011) Pathology of hereditary breast cancer. Cell Oncol (Dordr) 34 (2):: 71-88 doi:10.1007/s13402-011-0010-3.
5. Yoshida K, Miki Y, (2004) Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci 95 (11):: 866-71.
6. van der Groep P, Bouter A, Menko FH, van der Wall E, van Diest PJ, (2008) High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer. Breast Cancer Res Treat 111 (3):: 475-480 doi:10.1007/s10549-007-9817-z.
7. Gronwald J, Jauch A, Cybulski C, Schoell B, Böhm-Steuer B, et al. (2005) Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization. Int J Cancer 20 114 (2):: 230-6.
8. Folkman J, Watson K, Ingber D, Hanahan D, (1989) Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339 (6219):: 58-61 doi:10.1038/339058a0.
9. Hanahan D, Folkman J, (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 (3):: 353-364 doi:S0092-8674(00)80108-7.
10. Carmeliet P, Jain RK, (2000) Angiogenesis in cancer and other diseases. Nature 407 (6801):: 249-257 doi:10.1038/35025220.
11. Prager GW, Poettler M, (2012) Angiogenesis in cancer. Basic mechanisms and therapeutic advances. Hamostaseologie 32 (2):: 105-114 doi: 1163 [pii]10.5482/ha-1163.
12. Ferrara N, (2009) VEGF-A: a critical regulator of blood vessel growth. Eur Cytokine Netw 20 (4):: 158-163 doi:10.1684/ecn.2009.0170.
13. Ferrara N, Gerber HP, LeCouter J, (2003) The biology of VEGF and its receptors. Nat Med 9 (6):: 669-676 doi:10.1038/nm0603-669 [pii].
14. Shibuya M, Claesson-Welsh L, (2006) Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 312 (5):: 549-560 doi: S0014-4827(05)00521-5 [pii]10.1016/j.yexcr.2005.11.012.
15. Bluff JE, Menakuru SR, Cross SS, Higham SE, Balasubramanian SP, et al. (2009) Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease. Br J Cancer 101 (4):: 666-672 doi: 6605196 [pii]10.1038/sj.bjc.6605196.
16. Guo S, Colbert LS, Fuller M, Zhang Y, Gonzalez-Perez RR, (2010) Vascular endothelial growth factor receptor-2 in breast cancer. Biochim Biophys Acta 1806 (1):: 108-121 doi: S0304-419X(10)00032-6 [pii]10.1016/j.bbcan.2010.04.004.
17. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L, (2006) VEGF receptor signalling- in control of vascular function. Nat Rev Mol Cell Biol 7 (5):: 359-371 doi: nrm1911 [pii]10.1038/nrm1911.
18. Semenza GL, (2000) HIF-1 and human disease: one highly involved factor. Genes Dev 14 (16):: 1983-1991.
19. Chaudary N, Hill RP, (2006) Hypoxia and metastasis in breast cancer. Breast Dis 26: 55-64.
20. Salceda S, Caro J, (1997) Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 272 (36):: 22642-22647.
21. Semenza GL, (2000) Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 35 (2):: 71-103 doi:10.1080/10409230091169186.
22. Ferrara N, Davis-Smyth T, (1997) The biology of vascular endothelial growth factor. Endocr Rev 18 (1):: 4-25.
23. Cao D, Hou M, Guan YS, Jiang M, Yang Y, et al. (2009) Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications. BMC Cancer 9: 432 doi: 1471-2407-9-432 [pii]10.1186/1471-2407-9-432.
24. Ahlgren J, Risberg B, Villman K, Bergh J, (2002) Angiogenesis in invasive breast carcinoma-a prospective study of tumour heterogeneity. Eur J Cancer 38 (1):: 64-69 doi:S0959804901003495 [pii].
25. Weis SM, Cheresh DA, (2011) Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med 17 (11):: 1359-1370 doi: nm.2537 [pii]10.1038/nm.2537.
26. Bos R, van Diest PJ, de Jong JS, van der Groep P, van der Valk P, et al. (2005) Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 46 (1):: 31-36 doi: HIS2045 [pii]10.1111/j.1365-2559.2005.02045.x.
27. Hansen S, Grabau DA, Sorensen FB, Bak M, Vach W, et al. (2000) Vascular grading of angiogenesis: prognostic significance in breast cancer. Br J Cancer 82 (2):: 339-347 doi: S0007092099909242 [pii]10.1054/bjoc.1999.0924.
28. Isobe T, Aoyagi K, Koufuji K, Shirouzu K, Kawahara A, et al. (2012) Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1alpha) expression in gastric cancer. Int J Clin Oncol doi:10.1007/s10147-012-0378-8.
29. Tommasi S, Crapolicchio A, Lacalamita R, Bruno M, Monaco A, et al. (2005) BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy. Mutat Res 578 (1-2):: 395-405 doi: S0027-5107(05)00250-2 [pii]10.1016/j.mrfmmm.2005.06.010.
30. Mangia A, Chiriatti A, Tommasi S, Menolascina F, Petroni S, et al. (2009) BRCA1 expression and molecular alterations in familial breast cancer. Histol Histopathol 24 (1):: 69-76.
31. El-Gendi S, Abdel-Hadi M, (2009) Lymphatic vessel density as prognostic factor in breast carcinoma: relation to clinicopathologic parameters. J Egypt Natl Canc Inst 21 (2):: 139-149.
32. Mangia A, Chiriatti A, Bellizzi A, Malfettone A, Stea B, et al. (2009) Biological role of NHERF1 protein expression in breast cancer. Histopathology 55 (5):: 600-608 doi: HIS3424 [pii]10.1111/j.1365-2559.2009.03424.x.
33. Tarnowski B, Chudecka-Glaz A, Gorski B, Rzepka-Gorska I, (2004) Vascular endothelial growth factor (VEGF) levels and mutation of the BRCA1 gene in breast cancer patients. Breast Cancer Res Treat 88 (3):: 287-288 doi:10.1007/s10549-004-0779-0.
34. Kang HJ, Kim HJ, Rih JK, Mattson TL, Kim KW, et al. (2006) BRCA1 plays a role in the hypoxic response by regulating HIF-1alpha stability and by modulating vascular endothelial growth factor expression. J Biol Chem 281 (19):: 13047-13056 doi: M513033200 [pii]10.1074/jbc.M513033200.
35. Kranz A, Mattfeldt T, Waltenberger J, (1999) Molecular mediators of tumor angiogenesis: enhanced expression and activation of vascular endothelial growth factor receptor KDR in primary breast cancer. Int J Cancer 84 (3):: 293-298 doi:10.1002/(SICI)1097-0215(19990621)84:3<293::AID-IJC16>3.0.CO;2- T [pii].
36. Delli Carpini J, Karam AK, Montgomery L, (2010) Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer. Angiogenesis 13 (1):: 43-58 doi:10.1007/s10456-010-9163-3.
37. Mori T, Sawada M, Kuroboshi H, Tatsumi H, Katsuyama M, et al. (2011) Estrogen-related receptor alpha expression and function are associated with vascular endothelial growth factor in human cervical cancer. Int J Gynecol Cancer 21 (4):: 609-615 doi:10.1097/IGC.0b013e3182017e9b/00009577-201105000-00005 [pii].
38. Tayama M, Furuhata T, Inafuku Y, Okita K, Nishidate T, et al. (2011) Vascular endothelial growth factor 165b expression in stromal cells and colorectal cancer. World J Gastroenterol 17 (44):: 4867-4874 doi:10.3748/wjg.v17.i44.4867.
39. Kawai H, Li H, Chun P, Avraham S, Avraham HK, (2002) Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells. Oncogene 21 (50):: 7730-7739 doi:10.1038/sj.onc.1205971.
40. Garzetti GG, Ciavattini A, Lucarini G, Pugnaloni A, De Nictolis M, et al. (1999) Vascular endothelial growth factor expression as a prognostic index in serous ovarian cystoadenocarcinomas: relationship with MIB1 immunostaining. Gynecol Oncol 73 (3):: 396-401 doi: S0090-8258(99)95377-5 [pii]10.1006/gyno.1999.5377.
41. Oda Y, Yamamoto H, Tamiya S, Matsuda S, Tanaka K, et al. (2006) CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis. Mod Pathol 19 (5):: 738-745 doi: 3800587 [pii]10.1038/modpathol.3800587.
42. Bich Trinh X, van Dam PA, Vermeulen PB, Van Laere SJ, Van den Eynden GG, et al. (2011) VEGF-A-independent and angiogenesis-dependent tumour growth in patients with metastatic breast cancer. Clin Transl Oncol 13 (11):: 805-808 doi:clat500 [pii].
43. Ali SH, O'Donnell AL, Balu D, Pohl MB, Seyler MJ, et al. (2000) Estrogen receptor-alpha in the inhibition of cancer growth and angiogenesis. Cancer Res 60 (24):: 7094-7098.
44. Kimbro KS, Simons JW, (2006) Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocr Relat Cancer 13 (3):: 739-749 doi: 13/3/739 [pii]10.1677/erc.1.00728.
45. Kioi M, Vogel H, Schultz G, Hoffman RM, Harsh GR, et al. (2010) Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest 120 (3):: 694-705 doi: 40283 [pii]10.1172/JCI40283.
46. Schindl M, Schoppmann SF, Samonigg H, Hausmaninger H, Kwasny W, et al. (2002) Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 8 (6):: 1831-1837.
47. Liu L, Ning X, Sun L, Zhang H, Shi Y, et al. (2008) Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci 99 (1):: 121-128 doi: CAS643 [pii]10.1111/j.1349-7006.2007.00643.x.
48. Yan M, Rayoo M, Takano EA, Fox SB, (2009) BRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression. Br J Cancer 101 (7):: 1168-1174 doi: 6605287 [pii]10.1038/sj.bjc.6605287.
49. Tsutsui S, Kume M, Era S, (2003) Prognostic value of microvessel density in invasive ductal carcinoma of the breast. Breast Cancer 10 (4):: 312-319.
50. Mohammed RA, Ellis IO, Mahmmod AM, Hawkes EC, Green AR, et al. (2011) Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance. Mod Pathol 24 (6):: 774-785 doi: modpathol20114 [pii]10.1038/modpathol.2011.4.
51. Uzzan B, Nicolas P, Cucherat M, Perret GY, (2004) Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res 64 (9):: 2941-2955.
52. Lynch BJ, Holden JA, Buys SS, Neuhausen SL, Gaffney DK, (1998) Pathobiologic characteristics of hereditary breast cancer. Hum Pathol 29 (10):: 1140-1144 doi:S0046-8177(98)90427-0 [pii].
53. Kuwai T, Kitadai Y, Tanaka S, Onogawa S, Matsutani N, et al. (2003) Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer 105 (2):: 176-181 doi:10.1002/ijc.11068.
54. Costello P, McCann A, Carney DN, Dervan PA, (1995) Prognostic significance of microvessel density in lymph node negative breast carcinoma. Hum Pathol 26 (11):: 1181-1184 doi:0046-8177(95)90190-6 [pii].
55. Medri L, Nanni O, Volpi A, Scarpi E, Dubini A, et al. (2000) Tumor microvessel density and prognosis in node-negative breast cancer. Int J Cancer 89 (1):: 74-80 doi:10.1002/(SICI)1097-0215(20000120)89:1<74:AID-IJC12>3.0.CO;2-L [pii].
56. Ranieri G, Labriola A, Achille G, Florio G, Zito AF, et al. (2002) Microvessel density, mast cell density and thymidine phosphorylase expression in oral squamous carcinoma. Int J Oncol 21 (6):: 1317-1323.